An international seminar on “Systemic Therapy for Cholangiocarcinoma” was successfully held online on 18 December 2020 by the Editorial Office of Hepatoma Research. The seminar was hosted by our Editor-in-Chief Prof. Guang-Wen Cao, Chairman of Department of Epidemiology, Second Military Medical University, Shanghai, China.
It is a great honor for us to invite Prof. Massimo Colombo, Chairman of the EASL International Liver Foundation and Prof. Stefano Cascinu, Past President of Italian Association of Medical Oncology from Italy, Prof. Ho-Seong Han, Chairman of Department of Surgery in Seoul National University Bundang Hospital from South Korea, Prof. Guo-Ming Shi and Prof. Xin-Rong Yang from Zhongshan Hospital of Fudan University, Prof. Feng Shen and Prof. Nan Li from Shanghai Eastern Hepatobiliary Surgery Hospital from China, to have this international academic communication together.
1. Welcome Speech from Editor-in-Chief
Prof. Cao expressed his sincere and warm welcome to all participants in the online seminar. It is great to have this international communication on research development of systemic therapy for Cholangiocarcinoma.
2. Discussion on Systemic Therapy for Advanced Cholangiocarcinoma: New Options on the Horizon
The article “Systemic therapy for advanced cholangiocarcinoma: new options on the horizon” from Prof Massimo Colombo’s team published in Hepatoma Research is liked and highly praised by many experts after the publication in October. In the seminar,Prof. Massimo Colombo and Prof. Cascinu Stefano discussed with Prof. Ho-Seong Han on this topic.
3. Scholars' Interaction
More experts discussed on the following topics in the seminar.
4. Free Discussion
Experts discussed "How to diagnose hepatitis B infection with HCC at an early stage and carry out active antiviral therapy to specifically reduce the incidence of HCC”, some young scholars also participated in the discussion.
Prof. Cao conveyed his thanks to all the participates and expressed his best wishes to all to stay safe and healthy during the COVID-19 period.
Hepatoma Research will hold more seminars next year, we look forward to inviting more experts and young scholars to participate and discuss together.
Respectfully submitted by the Editorial Office of Hepatoma Research.